CJC-1295 w/o DAC 5mg / Ipamorelin 5mg Blend
$74.99
A pre-formulated blend of CJC-1295 (5mg) and Ipamorelin (5mg) targeting synergistic GHRH/GHS pathways in growth hormone research. Single lyophilized vial for convenience. For research use only.
20 in stock
The CJC-1295 / Ipamorelin blend combines two growth hormone secretagogues with complementary mechanisms in a single lyophilized vial: CJC-1295 without DAC (Modified GRF 1-29, 5mg) and Ipamorelin (5mg). Together they stimulate growth hormone release through two independent but synergistic pathways — GHRH receptor activation and ghrelin receptor (GHS-R) activation — producing a more robust GH pulse than either compound alone.
Component Overview:
- CJC-1295 w/o DAC (5mg) — A GHRH analogue that stimulates pituitary somatotrophs to release GH with a short, physiological pulse pattern
- Ipamorelin (5mg) — A selective GHS-R agonist that stimulates GH release with minimal effect on cortisol or prolactin
Key Research Areas:
- Growth hormone secretagogue synergy research
- IGF-1 axis regulation and body composition
- Recovery, tissue repair, and anabolic signaling
- Sleep quality and GH pulsatility studies
- Age-related GH decline models
For research purposes only. Not for human or veterinary use. Store lyophilized vials at -20°C. After reconstitution with BAC water, refrigerate and use within 4–6 weeks.
Every batch sold by Alpha Peptides US is independently tested by a certified third-party laboratory. The Certificate of Analysis (CoA) below confirms the identity, purity, and net content of this product.
Testing performed by Freedom Diagnostics Testing via LC-MS/MS under standard laboratory conditions. Results are specific to the tested batch and are intended for research purposes only.
View Certificate of Analysis (PDF)Research use only. Not intended for human or veterinary use, diagnostic, therapeutic, or clinical applications.
Reviews
There are no reviews yet.